A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer

Clinical trial NCT01265927 · COMPLETED

Trial details

NCT number: NCT01265927
Sponsor: Indiana University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2011-01-01
Primary completion: 2012-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.